Combined functional genome survey of therapeutic targets for hepatocellular carcinoma

Clinical Cancer Research

Volumn 16, Issue 9, 2010, Pages 2518-2528

  Satow, Reiko ^a   Shitashige, Miki ^a   Kanai, Yae ^a   Takeshita, Fumitaka ^a   Ojima, Hidenori ^a   Jigami, Takafumi ^a   Honda, Kazufumi ^a   Kosuge, Tomoo ^b   Ochiya, Takahiro ^a   Hirohashi, Setsuo ^a   Yamada, Tesshi ^a  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^b NATIONAL CANCER CENTER HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ATELOCOLLAGEN; SMALL INTERFERING RNA;

AKR1B10 GENE; ANIMAL EXPERIMENT; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CELL PROLIFERATION; CHRONIC HEPATITIS; CONTROLLED STUDY; FEMALE; GENE; GENE EXPRESSION; GENE TARGETING; GENE THERAPY; GENETIC SCREENING; HCAP G GENE; HUMAN; HUMAN CELL; HUMAN TISSUE; KNOCKOUT GENE; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER DYSFUNCTION; MAJOR CLINICAL STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RRM2 GENE; TPX2 GENE; TUMOR XENOGRAFT;

AGED; ANIMALS; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL PROLIFERATION; CLUSTER ANALYSIS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC PREDISPOSITION TO DISEASE; GENOME, HUMAN; GENOME-WIDE ASSOCIATION STUDY; HUMANS; LIVER NEOPLASMS; LIVER NEOPLASMS, EXPERIMENTAL; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TRANSPLANTATION, HETEROLOGOUS;

EID: 77951721529     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-09-2214     Document Type: Article

References (37)

1. El-Serag HB, Rudolph KL. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 2007;132:2557-2576 (Pubitemid 46890874)
2. Hernandez-Boluda JC, Cervantes F. Imatinib mesylate (Gleevec, Glivec):a new therapy for chronic myeloid leukemia and other malignancies. Drugs Today (Barc) 2002;38:601-613
3. Fong T, Morgensztern D, Govindan R. EGFR inhibitors as first-line therapy in advanced non-small cell lung cancer. J Thorac Oncol 2008;3:303-310 (Pubitemid 351654331)
4. Llovet JM, Ricci S, Mazzaferro V, et al. Sorafenib in advanced hepatocellular carcinoma. N Engl J Med 2008;359:378-390
5. Di Maio M, Daniele B, Perrone F. Targeted therapies: role of sorafenib in HCC patients with compromised liver function. Nat Rev Clin Oncol 2009;6:505-506
6. Hideshima T, Chauhan D, Richardson P, Anderson KC. Identification and validation of novel therapeutic targets for multiple myeloma. J Clin Oncol 2005;23:6345-6350 (Pubitemid 46218845)
7. Izzo F, Marra P, Beneduce G, et al. Pegylated arginine deiminase treatment of patients with unresectable hepatocellular carcinoma: results from phase I/II studies. J Clin Oncol 2004;22:1815-1822 (Pubitemid 41095171)
8. Drew Y, Plummer R. The emerging potential of poly(ADP-ribose) polymerase inhibitors in the treatment of breast cancer. Curr Opin Obstet Gynecol 2010;22:67-71.
9. Whitehurst AW, Bodemann BO, Cardenas J, et al. Synthetic lethal screen identification of chemosensitizer loci in cancer cells. Nature 2007;446:815-819 (Pubitemid 46582032)
10. Silva JM, Marran K, Parker JS, et al. Profiling essential genes in human mammary cells by multiplex RNAi screening. Science 2008;319:617-620 (Pubitemid 351197063)
11. Schlabach MR, Luo J, Solimini NL, et al. Cancer proliferation gene discovery through functional genomics. Science 2008;319:620-624 (Pubitemid 351197064)
12. Luo B, Cheung HW, Subramanian A, et al. Highly parallel identification of essential genes in cancer cells. Proc Natl Acad Sci U S A 2008;105:20380-20385
13. Huang L, Shitashige M, Satow R, et al. Functional interaction of DNA topoisomerase IIα with the β-catenin and T-cell factor-4 complex. Gastroenterology 2007;133:1569-1578 (Pubitemid 350029741)
14. Shitashige M, Naishiro Y, Idogawa M, et al. Involvement of splicing factor-1 in β-catenin/T-cell factor-4-mediated gene transactivation and pre-mRNA splicing. Gastroenterology 2007;132:1039-1054 (Pubitemid 46440870)
15. Honda K, Yamada T, Hayashida Y, et al. Actinin-4 increases cell motility and promotes lymph node metastasis of colorectal cancer. Gastroenterology 2005;128:51-62. (Pubitemid 40039958)
16. Yamaguchi U, Nakayama R, Honda K, et al. Distinct gene expression-defined classes of gastrointestinal stromal tumor. J Clin Oncol 2008;26:4100-4108
17. Minakuchi Y, Takeshita F, Kosaka N, et al. Atelocollagen-mediated synthetic small interfering RNA delivery for effective gene silencing in vitro and in vivo. Nucleic Acids Res 2004;32:e109.
18. Takeshita F, Minakuchi Y, Nagahara S, et al. Efficient delivery of small interfering RNA to bone-metastatic tumors by using atelocollagen in vivo. Proc Natl Acad Sci U S A 2005;102:12177-12182 (Pubitemid 41291148)
19. Shi L, Reid LH, Jones WD, et al. The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements. Nat Biotechnol 2006;24:1151-1161 (Pubitemid 44359727)
20. Bolker BM, Brooks ME, Clark CJ, et al. Generalized linear mixed models: a practical guide for ecology and evolution. Trends Ecol Evol 2009;24:127-135
21. Gardina PJ, Clark TA, Shimada B, et al. Alternative splicing and differential gene expression in colon cancer detected by a whole genome exon array. BMC Genomics 2006;7:325. (Pubitemid 46165475)
22. Hussain SP, Schwank J, Staib F, Wang XW, Harris CC. TP53 mutations and hepatocellular carcinoma: insights into the etiology and pathogenesis of liver cancer. Oncogene 2007;26:2166-2176 (Pubitemid 46536641)
23. Gouas D, Shi H, Hainaut P. The aflatoxin-induced TP53 mutation at codon 249 (R249S): biomarker of exposure, early detection and target for therapy. Cancer Lett 2009;286:29-37.
24. Villanueva A, Newell P, Chiang DY, Friedman SL, Llovet JM. Genomics and signaling pathways in hepatocellular carcinoma. Semin Liver Dis 2007;27:55-76. (Pubitemid 46269805)
25. Katoh H, Shibata T, Kokubu A, et al. Genetic inactivation of the APC gene contributes to the malignant progression of sporadic hepatocellular carcinoma: a case report. Genes Chromosomes Cancer 2006;45:1050-1057 (Pubitemid 44435539)
26. Shao J, Zhou B, Chu B, Yen Y. Ribonucleotide reductase inhibitors and future drug design. Curr Cancer Drug Targets 2006;6:409-431 (Pubitemid 44033390)
27. Gruss OJ, Vernos I. The mechanism of spindle assembly: functions of Ran and its target TPX2. J Cell Biol 2004;166:949-955 (Pubitemid 39304757)
28. Bayliss R, Sardon T, Ebert J, Lindner D, Vernos I, Conti E. Determinants for Aurora-A activation and Aurora-B discrimination by TPX2. Cell Cycle 2004;3:404-407 (Pubitemid 40278221)
29. Marumoto T, Zhang D, Saya H. Aurora-A-a guardian of poles. Nat Rev Cancer 2005;5:42-50.
30. Keen N, Taylor S. Aurora-kinase inhibitors as anticancer agents. Nat Rev Cancer 2004;4:927-936
31. Harrington EA, Bebbington D, Moore J, et al. VX-680, a potent and selective small-molecule inhibitor of the Aurora kinases, suppresses tumor growth in vivo. Nat Med 2004;10:262-267 (Pubitemid 38667616)
32. Anderson K, Yang J, Koretke K, et al. Binding of TPX2 to Aurora A alters substrate and inhibitor interactions. Biochemistry 2007;46:10287-10295 (Pubitemid 350067622)
33. Gerlich D, Hirota T, Koch B, Peters JM, Ellenberg J. Condensin I stabilizes chromosomes mechanically through a dynamic interaction in live cells. Curr Biol 2006;16:333-344 (Pubitemid 43259343)
34. Lam WW, Peterson EA, Yeung M, Lavoie BD. Condensin is required for chromosome arm cohesion during mitosis. Genes Dev 2006;20:2973-2984 (Pubitemid 44771732)
35. Scuric Z, Stain SC, Anderson WF, Hwang JJ. New member of aldose reductase family proteins overexpressed in human hepatocellular carcinoma. Hepatology 1998;27:943-950 (Pubitemid 28160478)
36. Teramoto R, Minagawa H, Honda M, et al. Protein expression profile characteristic to hepatocellular carcinoma revealed by 2D-DIGE with supervised learning. Biochim Biophys Acta 2008;1784:764-772
37. Li CP, Goto A, Watanabe A, et al. AKR1B10 in usual interstitial pneumonia: expression in squamous metaplasia in association with smoking and lung cancer. Pathol Res Pract 2008;204:295-304.